Katayama syndrome

Lancet Infectious Diseases

Volumn 7, Issue 3, 2007, Pages 218-224

  Ross, Allen G ^a   Vickers, David ^b   Olds, G Richard ^c   Shah, Syed M ^a   McManus, Donald P ^d  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; PRAZIQUANTEL; STEROID;

ABDOMINAL TENDERNESS; ANAMNESIS; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; CLINICAL FEATURE; COUGHING; DIAGNOSTIC ERROR; DRUG CONTRAINDICATION; EOSINOPHILIA; FEVER; HEADACHE; HUMAN; HYPERSENSITIVITY; INFECTION PREVENTION; KATAYAMA SYNDROME; LUNG INFILTRATE; MYALGIA; NONHUMAN; PARASITE IDENTIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REINFECTION; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; SEROCONVERSION; SINGLE DRUG DOSE; SYMPTOM; SYNDROME; SYSTEMATIC REVIEW; TRAVEL;

ANIMALS; ARTEMISININS; HUMANS; PRAZIQUANTEL; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES; SESQUITERPENES; STEROIDS;

EID: 33847035457     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70053-1     Document Type: Review

References (60)

1. Morel C. Reaching maturity-25 years of the TDR. Parasitol Today 16 (2000) 522-528
2. Ross A., Bartley P., Sleigh A., et al. Schistosomiasis. N Engl J Med 346 (2002) 1212-1220
3. Blanchard T. Schistosomiasis. Travel Med Infect Dis 2 (2004) 5-11
4. CDC. Schistosomiasis. Travelers' health: yellow book, health information for international travel, 2005-2006 (2005), Centers for Disease Control and Prevention, Atlanta, GA
5. Burkhart C., and Burkhart C. Swimmer's itch: an assessment proposing possible treatment with ivermectin. Int J Dermatol 42 (2003) 917-918
6. Bottieau E., Clerinx J., de Vega M., et al. Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect 52 (2006) 339-345
7. Patz J., Graczyk T., Geller N., et al. Effects of environmental change on emerging parasitic diseases. Int J Parasitol 48 (2000) 121-124
8. Utzinger J., Xiao-Nong Z., Gang C.M., et al. Conquering schistosomiasis in China: the long march. Acta Trop 96 (2005) 69-96
9. Visser L., Polderman A., and Stuiver P. Outbreak of schistosomiasis among travellers returning from Mali, West Africa. Clin Infect Dis 20 (1995) 280-285
10. Colebunders R., Verstraeten T., Van Gompel A., et al. Acute schistosomiasis in travellers returning from Mali. J Travel Med 2 (1995) 235-238
11. Cooke G., Lalvani A., Gleeson F., et al. Acute pulmonary schistosomiasis in travellers returning from Lake Malawi, sub-Saharan Africa. Clin Infect Dis 29 (1999) 836-839
12. Schwartz E., Rozenman J., and Perelman M. Pulmonary manifestations of early schistosomiasis infection among nonimmune travellers. Am J Med 109 (2000) 718-722
13. Ki-Zerbo G., Receveur M., Malvy D., et al. Acute bilharziasis outbreak in a family visiting Mali. J Travel Med 8 (2001) 319-321
14. van Gool T., Vetter H., Vervoort T., Doenhoff M., Wetsteyn J., and Overbosch D. Serodiagnosis of imported schistosomiasis by a combination of commercial indirect hemagglutination test with Schistosoma mansoni adult worm antigens and an enzyme-linked immunosorbent assay with S mansoni egg antigens. J Clin Micro 40 (2002) 3432-3437
15. Enk M., Amorim A., and Schall V. Acute schistosomiasis outbreak in the metropolitan area of Belo Horizonte, Minas Gerais: alert about the risk of unnoticed transmission increased by growing rural tourism. Mem Inst Oswaldo Cruz 98 (2003) 745-750
16. Schwartz E., Kozarsky P., Wilson M., et al. Schistosome infection among river rafters on Omo River, Ethiopia. J Travel Med 12 (2005) 3-8
17. Shiff C. Epidemiology of helminth infections. In: Nelson K., Williams C.M., and Graham N. (Eds). Infectious disease epidemiology: theory and practice (2000), Aspen Publishers, Gaithersburg
18. Waine G., and McManus D. Schistosomiasis vaccine development-the current picture. Bioessays 19 (1997) 435-443
19. Appleton C. Schistosome dermatitis-an unrecognised problem in South Africa. S Afr Med J 65 (1984) 467-469
20. Lambertucci J., Rayes A., Barata C., et al. Acute schistosomiasis: Report on five singular cases. Mem Inst Oswaldo Cruz 92 (1997) 631-635
21. Yasaway M. Katayama syndrome. Saudi Med J 25 (2004) 234-236
22. Bouree P., and Caumes E. Cercarial dermatitis. Presse Med 33 (2004) 490-493 (in French).
23. Corachan C. Schistosomiasis and international travel. Clin Infect Dis 35 (2002) 446-450
24. Hiatt R., Sotomayor Z., and Sanchez G. Factors in pathogenesis of acute schistosomiasis. J Infect Dis 172 (1979) 1336-1342
25. Rocha M., Rocha R., Pedroso E., et al. Pulmonary manifestations in the initial phase of Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 37 (1995) 311-318
26. Ribeiro de Jesus A., Silva A., Santana L., et al. Clinical and immunologic evaluation of 31 patients with acute Schistosomiasis mansoni. J Infect Dis 185 (2002) 98-105
27. King C., Malhotra I., Mungai P., et al. B cell sensitization to helminthic infection develops in utero in humans. J Immunol 160 (1998) 3578-3584
28. Chen M. Schistosoma japonicum and S japonicum-like infections: epidemiology, clinical and patho-logical aspects. In: Jordan P., Webbe G., and Sturrock F. (Eds). Human schistosomiasis (1993), CAB International, Wallingford 237-270
29. Ross A., Sleigh A., Li Y., et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 14 (2001) 270-295
30. Alfred P. Schistosomiasis. In: Shakir R., Newman P., and Poser C. (Eds). Tropical neurology (1996), WB Saunders, Philadelphia
31. Fowler R., Lee C., and Keystone J. The role of corticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: case report and discussion. Am J Trop Med Hyg 61 (1999) 47-50
32. Tarp B., Black F., and Petersen E. The immunofluorescence antibody test (IFAT) for the diagnosis of schistosomiasis used in a non-endemic area. Trop Med Int Health 5 (2000) 185-191
33. Doenhoff M., Chiodini P., and Hamilton J. Specific and sensitive diagnosis of schistosome infection: can it be done with antibodies?. Trends Parasitol 20 (2004) 35-39
34. Bierman W., Wetsteyn J., and van Gool T. Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology. J Travel Med 12 (2005) 9-13
35. Cetron M., Chitsulo L., Sullivan J., et al. Schistosomiasis in Lake Malawi. Lancet 348 (1996) 1274-1278
36. Hamilton J., Klinkert M., and Doenhoff M. Diagnosis of schistosomiasis: antibody detection, with notes on parasitological and antigen detection methods. Parasitology 117 suppl (1998) S41-S57
37. Yin-Chang Z. Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop 96 (2005) 130-136
38. van Lieshout L., Polderman A., Visser L., et al. Detection of the circulating antigens CAA and CCA in a group of Dutch travellers with acute schistosomiasis. Trop Med Int Health 2 (1997) 551-557
39. van Lieshout L., Polderman A., and Deelder A. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop 77 (2000) 69-80
40. Doherty J., Moody A., and Wright S. Katayama fever: an acute manifestation of schistosomiasis. BMJ 313 (1996) 1071-1072
41. Fenwick A., Savioli L., Engels D., et al. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19 (2003) 509-515
42. Magnussen P. Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years' experiences. Acta Trop 86 (2003) 243-254
43. Olds R. Administration of praziquantel to pregnant and lactating women. Acta Trop 86 (2003) 185-195
44. Chen M. Use of praziquantel for clinical treatment and morbidity control of Schistosomiasis japonica in China: a review of 30 years' experience. Acta Trop 96 (2005) 168-176
45. Xiao S. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop 96 (2005) 153-167
46. Harries A., and Cook G. Acute schistosomiasis (Katayama fever) clinical deterioration after chemotherapy. J Infect 14 (1987) 159-161
47. Alonso D., Munoz J., Gascon J., et al. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg 74 (2006) 342-344
48. Botros S., Sayed H., Amer N., et al. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int J Parasitol 35 (2005) 787-791
49. Xiao S., Booth M., and Tanner M. The prophylactic effect of artemether against Schistosoma japonicum infection. Parasitol Today 16 (2000) 122-126
50. Li Y., Chen H., He H., et al. A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China. Acta Trop 96 (2005) 184-190
51. Utzinger J., N'Goran E., N'Dri A., Lengeler C., Shuhua X., and Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised control trial. Lancet 355 (2000) 1320-1325
52. Xiao S., Tanner M., N'Goran E., et al. Recent investigations of artemether, a novel agent for the prevention of schistomiasis japonica, mansoni and haematobia. Acta Trop 82 (2002) 175-181
53. Grandiere-Perez L., Ansart S., Paris L., et al. Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers. Am J Trop Med Hyg 74 (2006) 814-818
54. Jelinek T., Nothdurft H., and Loscher T. Schistosomiasis in travellers and expatriates. J Travel Med 3 (1996) 160-164
55. Hatz C. Schistosomiasis: an underestimated problem in industrialized countries?. J Travel Med 12 (2005) 1-2
56. Ramaswamy K., He Y., Salafsky B., et al. Topical application of DEET for schistosomiasis. Trends Parasitol 19 (2003) 5551-5555
57. Mahmoud A., and Wahab M. Schistosomiasis. In: Warren K., and Mahmoud A. (Eds). Tropical and geographical medicine (1990), McGraw-Hill, New York
58. Pearce E. Progress towards a vaccine for schistosomiasis. Acta Trop 86 (2003) 185-195
59. Siddiqui A., Phillips T., Charest H., et al. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through codelivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 21 (2003) 2882-2889
60. McManus D., and Bartley P. A vaccine against Asian schistosomiasis. Parasitol Int 53 (2004) 163-173